Cancer Immunology, Immunotherapy
A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy
Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3–5, 2011
Comment on “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy” by Gustav J. Ullenhag et al.
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C
Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma
Long-term proliferation of functional human NK cells, with conversion of CD56dim NK cells to a CD56bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy
Response to the letter to the editors from Inge Marie Svane on our manuscript “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy”
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells
Scutellaria extract and wogonin inhibit tumor-mediated induction of Treg cells via inhibition of TGF-ß1 activity
Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy